Keyphrases
Register-based
100%
Antipsychotic Polypharmacy
100%
Health Service Costs
100%
Cost Analysis
100%
High Cost
28%
Antipsychotic Monotherapy
28%
Health Service Use
28%
Risk Factors
14%
Potential Confounders
14%
Antipsychotics
14%
Psychiatric Inpatients
14%
Age of Diagnosis
14%
Schizophrenia
14%
Monotherapy
14%
Schizophrenia Spectrum Disorders
14%
Disease Duration
14%
Subgroup Analysis
14%
Resource Utilization
14%
Inpatient Treatment
14%
Danish Registers
14%
Polypharmacy
14%
Functional Level
14%
Co-prescribing
14%
Potential Risk
14%
Healthcare Service Use
14%
Multivariate Generalized Linear Model
14%
Inpatient Admission
14%
Comparative Analysis
14%
Mental Health Referrals
14%
Causal Relations
14%
Referral Center
14%
Treatment Site
14%
Resource Cost
14%
Nursing and Health Professions
Health Service
100%
Polypharmacy
100%
Cost Benefit Analysis
100%
Monotherapy
37%
Health Care Utilization
25%
Outpatient
12%
Patient Referral
12%
Disease Duration
12%
Dependent Variable
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Polypharmacy
100%
Monotherapy
33%
Observational Study
11%
Disease Duration
11%
Psychology
Schizophrenia
100%
Healthcare
50%
Generalized Linear Model
50%
Dependent Variable
50%